Skip to content

R2P MISAGO SXR07060RRecalls & reported problems

Terumo Corporation · MISAGO RX Self-expanding Peripheral Stent · Class 3 · Implant

All models of R2P MISAGO (13)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04987350727589), received between Nov 18, 2020 and Nov 18, 2020 — classified as 1 malfunction.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 18, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE USER FACILITY REPORTED THAT THE 7X60 MISAGO WAS IMPLANTED ON (B)(6) 2020 IN THE L COMMON ILIAC. THE PATIENT BECAME SYMPTOMATIC AND DETERMINED TO BE STENOSED UNDER FLUOROSCOPY. THEY PUT A 7X37 EV3 VISIPRO BALLOON EXPANDABLE STENT INSIDE THE MISAGO. WITHIN NINE MONTHS, THE STENT STENOSED REQUIRING INTERVENTION. THE PATIENT'S CONDITION WAS STABLE. RE-STENTING THE LEFT COMMON ILIAC WAS SUCCESSFUL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 10859857 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page